US Stock MarketDetailed Quotes

IMRX Immuneering

Watchlist
  • 2.200
  • -0.050-2.22%
Close Dec 31 16:00 ET
  • 2.290
  • +0.090+4.09%
Post 16:05 ET
68.31MMarket Cap-1.12P/E (TTM)

Immuneering Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-12.02%-13.47M
-7.23%-11.53M
-7.44%-15.49M
-11.04%-48.97M
-0.23%-11.78M
-13.22%-12.03M
-13.75%-10.75M
-17.40%-14.42M
-42.95%-44.1M
-27.16%-11.75M
Net income from continuing operations
-15.90%-14.6M
-15.52%-14.08M
-5.17%-14.31M
-5.86%-53.47M
-13.88%-15.08M
1.94%-12.6M
-5.74%-12.19M
-5.49%-13.6M
-50.63%-50.51M
-22.82%-13.25M
Operating gains losses
----
----
----
-23.81%3.94K
--2.46K
--0
--817
--666
--5.17K
----
Depreciation and amortization
12.45%96.27K
14.37%97.85K
16.32%97.53K
26.99%352.08K
15.32%97.07K
13.56%85.61K
203.15%85.56K
-58.21%83.84K
74.29%277.25K
60.35%84.18K
Change In working capital
17.25%-657.59K
2,577.24%724.49K
-28.38%-2.68M
-156.76%-974.64K
297.65%1.88M
-175.85%-794.68K
-96.54%27.06K
-256.48%-2.09M
90.72%1.72M
-54.72%473.7K
-Change in receivables
--0
--0
--0
-94.69%12.42K
--0
--0
-98.97%1.05K
133.87%11.37K
-16.48%233.62K
-76.98%57.76K
-Change in prepaid assets
21.25%-644.55K
-550.66%-788.13K
-51.47%248.9K
39.28%-172.66K
90.69%-41.95K
55.99%-818.49K
-71.67%174.88K
-63.60%512.9K
88.20%-284.35K
-163.17%-450.76K
-Change in payables and accrued expense
117.96%156.22K
3,644.43%1.74M
-4.79%-2.65M
-117.22%-384.91K
133.84%2.12M
-97.77%71.68K
-146.39%-49.06K
-27.02%-2.52M
-28.15%2.23M
753.44%905.21K
-Change in other current assets
---67.69K
---223.64K
--30K
19.28%-290.74K
-7,020.79%-290.74K
--0
--0
--0
---360.2K
---4.08K
-Change in other current liabilities
-112.21%-101.57K
97.36%-2.64K
-250.60%-317.84K
-30.18%-138.75K
389.22%99.58K
-10.99%-47.87K
-138.26%-99.81K
-804.94%-90.66K
-31.83%-106.59K
-40.39%-34.43K
Cash from discontinued investing activities
Operating cash flow
-12.02%-13.47M
-7.23%-11.53M
-7.44%-15.49M
-11.04%-48.97M
-0.23%-11.78M
-13.22%-12.03M
-13.75%-10.75M
-17.40%-14.42M
-42.95%-44.1M
-27.16%-11.75M
Investing cash flow
Cash flow from continuing investing activities
77.41%-5.42M
-45.79%4.97M
12.76%21.39M
-82.56%7.3M
-61.57%3.13M
-2,623.83%-23.97M
-58.64%9.16M
52.94%18.97M
155.32%41.83M
135.74%8.15M
Net PPE purchase and sale
90.78%-5.27K
62.19%-32.77K
-33.88%-37.48K
53.84%-342.75K
-146.63%-170.92K
85.46%-57.15K
47.46%-86.69K
75.67%-27.99K
-1,121.47%-742.48K
-430.97%-69.3K
Net investment purchase and sale
77.38%-5.41M
-45.95%5M
12.79%21.43M
-82.06%7.64M
-59.82%3.3M
-4,811.18%-23.91M
-58.56%9.25M
51.76%19M
156.30%42.57M
135.96%8.22M
Cash from discontinued investing activities
Investing cash flow
77.41%-5.42M
-45.79%4.97M
12.76%21.39M
-82.56%7.3M
-61.57%3.13M
-2,623.83%-23.97M
-58.64%9.16M
52.94%18.97M
155.32%41.83M
135.74%8.15M
Financing cash flow
Cash flow from continuing financing activities
20,249.61%4.36M
0
309.31%979.92K
149,558.35%28.44M
104.24%7.84K
224.60%21.45K
101,297.86%28.17M
23.97%239.41K
-99.99%19K
-2,556.14%-184.68K
Net common stock issuance
--4.24M
----
----
--28.2M
--0
--0
----
----
--0
--0
Proceeds from stock option exercised by employees
493.00%127.19K
--0
309.31%979.92K
48.09%444.84K
-81.39%7.84K
-42.63%21.45K
533.99%176.15K
23.97%239.41K
-76.56%300.38K
459.89%42.1K
Net other financing activities
----
----
----
27.58%-203.77K
--0
--0
----
----
86.75%-281.38K
---226.78K
Cash from discontinued financing activities
Financing cash flow
20,249.61%4.36M
--0
309.31%979.92K
149,558.35%28.44M
104.24%7.84K
224.60%21.45K
101,297.86%28.17M
23.97%239.41K
-99.99%19K
-2,556.14%-184.68K
Net cash flow
Beginning cash position
-42.58%59.73M
-14.39%66.29M
-18.22%59.41M
-3.01%72.64M
-10.96%68.04M
18.29%104.02M
2.96%77.43M
-3.01%72.64M
101.91%74.89M
-28.53%76.42M
Current changes in cash
59.63%-14.52M
-124.67%-6.56M
43.56%6.88M
-487.72%-13.23M
-128.37%-8.63M
-212.31%-35.98M
108.82%26.59M
1,412.52%4.79M
-105.96%-2.25M
88.20%-3.78M
End cash Position
-33.56%45.21M
-42.58%59.73M
-14.39%66.29M
-18.22%59.41M
-18.22%59.41M
-10.96%68.04M
18.29%104.02M
2.96%77.43M
-3.01%72.64M
-3.01%72.64M
Free cash flow
-11.53%-13.48M
-6.68%-11.56M
-7.49%-15.53M
-9.96%-49.31M
-1.08%-11.95M
-9.70%-12.08M
-12.70%-10.84M
-16.54%-14.45M
-45.07%-44.84M
-27.73%-11.82M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -12.02%-13.47M-7.23%-11.53M-7.44%-15.49M-11.04%-48.97M-0.23%-11.78M-13.22%-12.03M-13.75%-10.75M-17.40%-14.42M-42.95%-44.1M-27.16%-11.75M
Net income from continuing operations -15.90%-14.6M-15.52%-14.08M-5.17%-14.31M-5.86%-53.47M-13.88%-15.08M1.94%-12.6M-5.74%-12.19M-5.49%-13.6M-50.63%-50.51M-22.82%-13.25M
Operating gains losses -------------23.81%3.94K--2.46K--0--817--666--5.17K----
Depreciation and amortization 12.45%96.27K14.37%97.85K16.32%97.53K26.99%352.08K15.32%97.07K13.56%85.61K203.15%85.56K-58.21%83.84K74.29%277.25K60.35%84.18K
Change In working capital 17.25%-657.59K2,577.24%724.49K-28.38%-2.68M-156.76%-974.64K297.65%1.88M-175.85%-794.68K-96.54%27.06K-256.48%-2.09M90.72%1.72M-54.72%473.7K
-Change in receivables --0--0--0-94.69%12.42K--0--0-98.97%1.05K133.87%11.37K-16.48%233.62K-76.98%57.76K
-Change in prepaid assets 21.25%-644.55K-550.66%-788.13K-51.47%248.9K39.28%-172.66K90.69%-41.95K55.99%-818.49K-71.67%174.88K-63.60%512.9K88.20%-284.35K-163.17%-450.76K
-Change in payables and accrued expense 117.96%156.22K3,644.43%1.74M-4.79%-2.65M-117.22%-384.91K133.84%2.12M-97.77%71.68K-146.39%-49.06K-27.02%-2.52M-28.15%2.23M753.44%905.21K
-Change in other current assets ---67.69K---223.64K--30K19.28%-290.74K-7,020.79%-290.74K--0--0--0---360.2K---4.08K
-Change in other current liabilities -112.21%-101.57K97.36%-2.64K-250.60%-317.84K-30.18%-138.75K389.22%99.58K-10.99%-47.87K-138.26%-99.81K-804.94%-90.66K-31.83%-106.59K-40.39%-34.43K
Cash from discontinued investing activities
Operating cash flow -12.02%-13.47M-7.23%-11.53M-7.44%-15.49M-11.04%-48.97M-0.23%-11.78M-13.22%-12.03M-13.75%-10.75M-17.40%-14.42M-42.95%-44.1M-27.16%-11.75M
Investing cash flow
Cash flow from continuing investing activities 77.41%-5.42M-45.79%4.97M12.76%21.39M-82.56%7.3M-61.57%3.13M-2,623.83%-23.97M-58.64%9.16M52.94%18.97M155.32%41.83M135.74%8.15M
Net PPE purchase and sale 90.78%-5.27K62.19%-32.77K-33.88%-37.48K53.84%-342.75K-146.63%-170.92K85.46%-57.15K47.46%-86.69K75.67%-27.99K-1,121.47%-742.48K-430.97%-69.3K
Net investment purchase and sale 77.38%-5.41M-45.95%5M12.79%21.43M-82.06%7.64M-59.82%3.3M-4,811.18%-23.91M-58.56%9.25M51.76%19M156.30%42.57M135.96%8.22M
Cash from discontinued investing activities
Investing cash flow 77.41%-5.42M-45.79%4.97M12.76%21.39M-82.56%7.3M-61.57%3.13M-2,623.83%-23.97M-58.64%9.16M52.94%18.97M155.32%41.83M135.74%8.15M
Financing cash flow
Cash flow from continuing financing activities 20,249.61%4.36M0309.31%979.92K149,558.35%28.44M104.24%7.84K224.60%21.45K101,297.86%28.17M23.97%239.41K-99.99%19K-2,556.14%-184.68K
Net common stock issuance --4.24M----------28.2M--0--0----------0--0
Proceeds from stock option exercised by employees 493.00%127.19K--0309.31%979.92K48.09%444.84K-81.39%7.84K-42.63%21.45K533.99%176.15K23.97%239.41K-76.56%300.38K459.89%42.1K
Net other financing activities ------------27.58%-203.77K--0--0--------86.75%-281.38K---226.78K
Cash from discontinued financing activities
Financing cash flow 20,249.61%4.36M--0309.31%979.92K149,558.35%28.44M104.24%7.84K224.60%21.45K101,297.86%28.17M23.97%239.41K-99.99%19K-2,556.14%-184.68K
Net cash flow
Beginning cash position -42.58%59.73M-14.39%66.29M-18.22%59.41M-3.01%72.64M-10.96%68.04M18.29%104.02M2.96%77.43M-3.01%72.64M101.91%74.89M-28.53%76.42M
Current changes in cash 59.63%-14.52M-124.67%-6.56M43.56%6.88M-487.72%-13.23M-128.37%-8.63M-212.31%-35.98M108.82%26.59M1,412.52%4.79M-105.96%-2.25M88.20%-3.78M
End cash Position -33.56%45.21M-42.58%59.73M-14.39%66.29M-18.22%59.41M-18.22%59.41M-10.96%68.04M18.29%104.02M2.96%77.43M-3.01%72.64M-3.01%72.64M
Free cash flow -11.53%-13.48M-6.68%-11.56M-7.49%-15.53M-9.96%-49.31M-1.08%-11.95M-9.70%-12.08M-12.70%-10.84M-16.54%-14.45M-45.07%-44.84M-27.73%-11.82M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Ecopetrol
EC
+3.13%
Petroleo Brasileiro SA Petrobras
PBR
+0.78%
Meritage Homes
MTH
+0.25%
KB Home
KBH
+0.21%
Taylor Morrison Home
TMHC
+0.18%

Unlock the Full List